MCIS Insurance Berhad (MCIS Life) and the National Cancer Society of Malaysia (NCSM) have launched LungShield, a new screening package designed to facilitate early detection of lung cancer while providing insurance protection for individuals considered at higher risk.
The programme, which has received backing from the Ministry of Health, was officially launched in a ceremony attended by Health Minister Datuk Seri Dr Dzulkefly Ahmad.
Lung cancer continues to pose a significant health challenge in Malaysia. According to the Malaysia National Cancer Registry Report 2017-2021, the disease ranks as the second most prevalent cancer among men and the third among women. Late-stage detection remains common, often leading to lower survival rates and higher treatment expenses.
LungShield is structured to offer a full diagnostic pathway. The package starts with an AI-assisted chest X-ray, followed by advanced diagnostic procedures such as Computed Tomography of the Thorax, Abdomen, and Pelvis (CT TAP), and immunohistochemistry for staging and confirmation.
In addition to diagnostic services, the package includes the LungLife insurance plan, which provides up to RM10,000 in coverage for one year. This insurance component is intended to help policyholders manage the costs associated with screening and further diagnostic work.
MCIS Life chief executive officer Prasheem Seebran highlighted the collaborative nature of the initiative.
“LungShield reflects the power of collaboration, combining NCSM’s expertise in cancer prevention and screening with MCIS Life’s commitment to financial support for early detection and diagnosis. Together, we are enabling more Malaysians to take proactive steps for their lung health, ensuring they have both the means to detect early and the confidence to face the journey ahead,” he said, as reported by Borneo Post.
Seebran also noted that the use of AI technology in screening can improve the likelihood of timely intervention, which is critical for effective treatment.
Health Minister Dzulkefly Ahmad commented on the alignment of LungShield with national health objectives.
“Lung cancer is among the leading causes of cancer deaths in Malaysia, mainly due to late detection. Affordable and accessible programmes like LungShield can save lives and ease the strain on our healthcare system,” he said, as reported by Borneo Post.
Dr Murallitharan Munisamy, managing director of NCSM, pointed out that the programme is designed to address both the clinical and financial challenges faced by individuals at risk of lung cancer.
“Our mission at NCSM has always been to ensure that no Malaysian is left behind in the fight against cancer. With LungShield, we are providing cutting-edge tools for early detection alongside financial support to ease the journey of those at risk,” he said.
The introduction of LungShield marks a step forward in the integration of health technology and insurance solutions in Malaysia.
By combining early detection tools with financial protection, the initiative aims to reduce barriers to screening and diagnosis.
Insurance professionals may view this development as part of a broader trend toward preventive care and value-added services within the industry.
As the sector continues to evolve, similar collaborations between insurers and healthcare organisations may become increasingly important in addressing public health challenges and supporting policyholders through comprehensive risk management strategies.
